Clinical evaluation of the bispecific antibody MDX-H210 (anti-Fc gamma RI x anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (filgrastim) for treatment of advanced breast cancer (Q74066671)
Jump to navigation
Jump to search
scientific article published on 01 November 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical evaluation of the bispecific antibody MDX-H210 (anti-Fc gamma RI x anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (filgrastim) for treatment of advanced breast cancer |
scientific article published on 01 November 1997 |
Statements
Clinical evaluation of the bispecific antibody MDX-H210 (anti-Fc gamma RI x anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (filgrastim) for treatment of advanced breast cancer (English)
H H van Ojik
R Repp
G Groenewegen
T Valerius
J G van de Winkel
1 November 1997